DiamiR LLC
http://www.diamirbio.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From DiamiR LLC
OSE Immunotherapeutics To Bolster R&D, Post-Janssen Option
The exercising by Janssen Biotech of an option to develop OSE Immunotherapeutics’ Phase II-ready antibody fragment for autoimmune and transplant-associated disorders will give an early boost to the French biotech that only completed a merger several weeks ago.
Medtech Execs On The Move, February 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Company Information
- Industry
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice